Genetics
Cancer Genetics Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option — so you and your clinician can compare before you book.
3 min read
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Cancer Genetics investigations
All 59 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| 1p & 19q Test TEST-1881 LOINC 49296-6 | This diagnostic test evaluates for the co-deletion of chromosome arms 1p and 19q in glioma tissue samples. | Formalin-fixed paraffin-embedded (FFPE) tumour tissue block or 10 unstained slides | 7–8 working days | 1,600.00 AED | Details |
| AKT1 Gene Cowden Syndrome Type 6 Genetic Test TEST-2104 LOINC 96504-5 | This genetic test identifies pathogenic germline variants in the AKT1 gene associated with an increased risk of hereditary cancers, particularly Cowde... | Peripheral whole blood (DNA FTA card) | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| ALK Gene (Neuroblastoma Type 3, Familial) Susceptibility NGS Test TEST-2506 LOINC 74057-6 | This test evaluates the ALK gene for hereditary mutations associated with familial neuroblastoma type 3. | Whole Blood, Extracted DNA, or Fingerpick FTA Card | 12 Business Days | 2,800.00 AED | Details |
| ALK/EML4 (NSCLC) Gene Rearrangement Test TEST-1870 LOINC 62458-1 | This test detects the presence of ALK/EML4 gene rearrangements in tumor tissue using FISH technology. | Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Unstained Slides | 4–5 Working Days | 1,400.00 AED | Details |
| APC Gene (Familial Adenomatous Polyposis Coli) Genetic Test TEST-2093 LOINC 21636-6 | This genetic test detects pathogenic variants in the APC gene associated with Familial Adenomatous Polyposis (FAP). | Peripheral Whole Blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| BAP1 Tumor Predisposition Syndrome Genetic Test TEST-1885 LOINC 97656-5 | This genetic test detects germline mutations in the BAP1 gene associated with an increased risk of multiple hereditary cancer syndromes. | Peripheral Whole Blood (also acceptable: dried DNA FTA card) | 3–4 Weeks | 2,800.00 AED | Details |
| BARD1 Gene Breast Cancer Susceptibility Genetic Test TEST-2151 LOINC 91156-2 | This genetic test evaluates for germline mutations within the BARD1 gene, a tumour suppressor associated with hereditary breast cancer susceptibility. | Whole Blood (Peripheral) | 3–4 weeks | 2,800.00 AED | Details |
| BRAF Gene Exon 15 Sequencing (Genetic Test) TEST-2131 LOINC 49590-1 | This test identifies activating mutations in the BRAF gene, specifically within exon 15, using Next-Generation Sequencing. | Peripheral Whole Blood (EDTA) or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| CALR Exon 9 Mutation Analysis (NGS) Test TEST-2138 LOINC 94477-5 | This test detects somatic insertions and deletions within the CALR exon 9 region using Next-Generation Sequencing (NGS). It is used for the diagnosis... | Whole Blood (Peripheral) | 10–15 business days | 2,800.00 AED | Details |
| CALR Mutation Analysis (Exon 9) Test TEST-1744 LOINC 94758-5 | This test detects mutations (insertions/deletions) in exon 9 of the CALR gene using Sanger sequencing. | Peripheral Whole Blood (EDTA) | 7–8 working days | 1,200.00 AED | Details |
| CCND1 Gene Hereditary Colorectal Cancer Susceptibility Genetic Test TEST-2113 LOINC 78999-1 | This genetic test evaluates the CCND1 gene for mutations that increase the risk of developing hereditary colorectal cancer. | Peripheral Whole Blood or FTA Card (Dried Blood Spot) | 3 – 4 Weeks | 2,800.00 AED | Details |
| CDK4 Gene Melanoma (Familial Cutaneous Malignant) Genetic Test TEST-2011 LOINC 21636-7 | This genetic test evaluates for inherited mutations in the CDK4 gene, which are associated with an increased risk of familial cutaneous malignant mela... | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| CDKN2A Gene Melanoma, Cutaneous Malignant, Familial Genetic Test TEST-1999 LOINC 21658-0 | This test evaluates the CDKN2A gene for inherited mutations associated with an increased risk of familial melanoma. | Peripheral whole blood (EDTA) or dried blood spot (FTA card) | 3 – 4 weeks | 2,800.00 AED | Details |
| Chromosome 11q Deletion (ATM) FISH Test TEST-1660 LOINC 53929-6 | This diagnostic test evaluates for the presence of a deletion in the ATM gene locus on chromosome 11q22.3 using Fluorescence In-Situ Hybridization (FI... | Bone marrow aspirate or peripheral blood | 3–4 business days | 700.00 AED | Details |
| DICER1 Gene Pleuropulmonary Blastoma Genetic Test TEST-1923 LOINC 82939-0 | This test evaluates for germline mutations in the DICER1 gene associated with hereditary predisposition to pleuropulmonary blastoma and DICER1 syndrom... | Whole Blood EDTA, Extracted DNA, FTA Card finger-prick | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| EGFR Gene Non-Small Cell Lung Cancer Familial Susceptibility Genetic Test TEST-1965 LOINC 21696-5 | This test evaluates the entire coding region of the EGFR gene for germline variants associated with an increased risk of non-small cell lung cancer. | Whole Blood (Peripheral) or FTA Card Dried Blood Spot | 3-4 Weeks | 2,800.00 AED | Details |
| EpCAM Gene (Lynch Syndrome Type 8) Genetic Test TEST-2092 LOINC 79747-6 | This genetic test sequences the EpCAM gene to detect mutations associated with Lynch syndrome type 8, a hereditary cancer predisposition syndrome. | Peripheral whole blood (venous draw) or dried blood spot on FTA card | 14–21 business days from sample receipt | 2,800.00 AED | Details |
| EZH2 Gene Leukemia, Lymphoblastic & Myeloid EZH2‑Related Genetic Test TEST-2035 LOINC 92736-8 | This diagnostic test evaluates the EZH2 gene for mutations associated with lymphoblastic and myeloid leukaemia. | Whole Blood (Peripheral) – EDTA Tube | 3–4 Weeks | 2,800.00 AED | Details |
| FOXO1 Break-Apart FISH (Alveolar Rhabdomyosarcoma) Diagnostic Test TEST-1578 LOINC 94470-2 | This diagnostic test evaluates formalin-fixed paraffin-embedded tumor tissue for the presence of PAX3-FOXO1 or PAX7-FOXO1 gene fusions using Fluoresce... | Formalin-Fixed Paraffin-Embedded (FFPE) tumor tissue block or biopsy slides | 7–8 working days | 1,200.00 AED | Details |
| Genetic Mapping for Oncology / Cancer Test TEST-1339 LOINC 81247-9 | This test evaluates germline DNA for hundreds of cancer-susceptibility genes using a SNP microarray and chromosomal microarray. | Peripheral whole blood (3 mL) in EDTA tube | 8 weeks from sample receipt | 2,700.00 AED | Details |
| HNF1A Germline Mutation Genetic Test for Renal Cell Carcinoma (NGS) TEST-1907 LOINC 101230-7 | This genetic test identifies inherited mutations in the HNF1A gene associated with an increased risk of renal cell carcinoma. | Whole blood (peripheral venipuncture) | 3 to 4 weeks | 2,800.00 AED | Details |
| HOXB13 Gene (Prostate Cancer, Familial) Genetic Test TEST-1905 LOINC 81258-4 | This test evaluates the HOXB13 gene for germline variants associated with an increased risk of developing prostate cancer. | Whole Blood (3 to 5 mL in EDTA tube) or FTA Card Blood Spot | 3 to 4 Weeks | 2,800.00 AED | Details |
| IDH1 Exon 4 Mutation Analysis (NGS) Test TEST-2042 LOINC 91783-8 | This test identifies mutations in exon 4 of the IDH1 gene using Next-Generation Sequencing (NGS). It helps guide treatment decisions for specific canc... | Peripheral whole blood (EDTA) or FFPE tissue block | 3–4 Weeks (21–28 business days) | 2,800.00 AED | Details |
| IDH2 Gene Exon 4 Sequencing (NGS) Test TEST-2066 LOINC 92618-6 | This test detects specific mutations within the fourth exon of the IDH2 gene, which are associated with AML and MDS. | Peripheral Whole Blood or FTA Card Dried Blood Spot | 3 to 4 Weeks | 2,800.00 AED | Details |
| KRAS Gene Mutation Analysis for Acute Myelogenous Leukemia, Genetic Test TEST-2046 LOINC 21659-8 | This test identifies somatic mutations in the KRAS gene using Next-Generation Sequencing (NGS) to aid in the prognosis and treatment selection for Acu... | Peripheral Whole Blood (or FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| MC1R Gene Melanoma, Cutaneous Malignant Genetic Test TEST-2005 LOINC 92828-0 | This genetic test evaluates the MC1R gene for mutations associated with an increased risk of cutaneous malignant melanoma. | Whole Blood (EDTA tube), Extracted DNA, or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| MET Gene Amplification (FISH) Test TEST-1189 LOINC 48647-3 | This diagnostic test evaluates the number of copies of the MET gene within tumor cells. | Tumor Tissue (FFPE Block / Biopsy Slides) | 4 Working Days | 1,200.00 AED | Details |
| Microsatellite Instability (MSI) Testing for Lynch Syndrome & Colorectal Cancer Test TEST-1336 LOINC 59040-5 | This diagnostic test evaluates the stability of microsatellites within a patient's DNA to detect defects in DNA mismatch repair mechanisms. | Archival Tumor Tissue Block (FFPE) and Peripheral Blood | 7–8 business days | 2,000.00 AED | Details |
| MLH1 Gene Mismatch Repair Cancer Syndrome Genetic Test TEST-1983 LOINC 21629-9 | This genetic test evaluates the MLH1 gene for mutations associated with Lynch syndrome, a hereditary cancer predisposition. | Peripheral Whole Blood (3–5 mL in EDTA tube) | 3–4 Weeks (expedited available) | 2,800.00 AED | Details |
| MLH3 Gene Colorectal Cancer, Hereditary Nonpolyposis Type 7 (Lynch Syndrome) Genetic Test TEST-2118 LOINC 82378-1 | This test evaluates the MLH3 gene for pathogenic variants linked to Hereditary Nonpolyposis Colorectal Cancer (HNPCC), also known as Lynch syndrome ty... | Peripheral Blood (Whole Blood) – EDTA Tube | 3–4 Weeks | 2,800.00 AED | Details |
| MN1 Gene Meningioma & MN1 Deficiency Genetic Test TEST-2004 LOINC 48018-6 | This test evaluates the MN1 gene for mutations associated with an increased risk of developing meningioma and MN1-deficiency syndromes. | Peripheral whole blood (venous or dried blood spot [FTA card]) | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| MSH6 Gene Endometrial Cancer, Familial, MSH6-Related Genetic Test TEST-2072 LOINC 21636-1 | This test evaluates the MSH6 gene for mutations associated with hereditary endometrial cancer and Lynch syndrome. | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| MUTYH Gene Familial Adenomatous Polyposis Type 2 Genetic Test TEST-2067 LOINC 21636-6 | This genetic test identifies pathogenic mutations in the MUTYH gene associated with an increased risk of colorectal cancer. | Peripheral whole blood or buccal swab | 3–4 weeks | 2,800.00 AED | Details |
| NDUFA13 Genetic Test for Hurthle Cell Thyroid Carcinoma TEST-2069 LOINC 81247-9 | This test evaluates for germline mutations in the NDUFA13 gene, which are associated with an increased hereditary risk of Hurthle cell thyroid carcino... | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| NRAS Mutation Analysis (Codons 12, 13, and 61) Test TEST-2687 LOINC 48767-7 | This test detects specific mutations in the NRAS gene (codons 12, 13, 61) within tumor tissue. | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Archival Specimen | 6 working days | 1,500.00 AED | Details |
| NTHL1 Gene Familial Adenomatous Polyposis Type 3 Genetic Test TEST-2089 LOINC 58130-9 | This genetic test evaluates the NTHL1 gene for mutations associated with familial adenomatous polyposis type 3. | Whole blood (EDTA), extracted DNA, or FTA card | 3–4 weeks | 2,800.00 AED | Details |
| OncoDx Panel Genetic Test TEST-2150 LOINC 94282-2 | This test evaluates genetic variations in 67 genes associated with hereditary cancer syndromes. | Peripheral whole blood (8–10 mL in EDTA lavender-top tube) | 3–4 weeks from sample receipt at laboratory | 3,000.00 AED | Details |
| OncoPro BRAF Rapid Test TEST-2803 LOINC 59041-3 | This test detects the presence of the BRAF V600E mutation in FFPE tumor tissue. | Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block | 2 working days | 2,900.00 AED | Details |
| PALB2 Gene Breast Cancer Susceptibility Genetic Test TEST-2122 LOINC 94083-9 | This genetic test evaluates the PALB2 gene for pathogenic variants associated with increased breast and pancreatic cancer risk. | Peripheral whole blood | 21–28 Days | 2,800.00 AED | Details |
| PDGFB Gene Familial Meningioma Genetic Test TEST-1990 LOINC 21636-6 | This test evaluates the entire coding region of the PDGFB gene for germline mutations associated with hereditary meningioma. | Whole blood (EDTA), extracted DNA, or FTA card blood spot | 3–4 Weeks | 2,800.00 AED | Details |
| PMS2 Gene Genetic Test for Lynch Syndrome TEST-1996 LOINC 21669-3 | This genetic test evaluates for mutations in the PMS2 gene, a key component of the DNA mismatch repair system, associated with an increased risk of Ly... | Whole Blood (EDTA) or Extracted DNA or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| RAD50 Gene Hereditary Breast and Ovarian Cancer Syndrome (HBOC) Test TEST-2073 LOINC 97765-3 | This genetic test evaluates the RAD50 gene for pathogenic variants associated with an increased risk of hereditary breast and ovarian cancer. | Peripheral Whole Blood (EDTA tube) | 3 – 4 Weeks | 2,800.00 AED | Details |
| RET Gene Multiple Endocrine Neoplasia Type 2B (MEN2B) Genetic Test TEST-1967 LOINC 21673-2 | This test analyzes the entire RET gene for mutations linked to Multiple Endocrine Neoplasia Type 2B (MEN2B), a hereditary cancer syndrome. | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test TEST-1882 LOINC 86223-0 | This genetic test evaluates the RHBDF2 gene for pathogenic variants associated with Tylosis with Esophageal Cancer syndrome. | Peripheral Whole Blood (EDTA) | 21–28 Calendar Days (3–4 Weeks) | 2,800.00 AED | Details |
| RINT1 Gene Breast Cancer Genetic Test TEST-2125 LOINC 81247-9 | This test evaluates the RINT1 gene for mutations associated with hereditary breast cancer and Lynch syndrome risk. | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| ROS1 Gene Rearrangement (NSCLC) FISH Test TEST-1151 LOINC 94499-2 | This diagnostic test evaluates for the presence of ROS1 gene rearrangements in non-small cell lung cancer tissue samples using Fluorescence In Situ Hy... | Tissue (FFPE block or slide) | 7–8 working days | 1,400.00 AED | Details |
| SDHAF2 Gene (Hereditary Paraganglioma-Pheochromocytoma Type 5) Genetic Test TEST-1932 LOINC 100218-4 | This genetic test evaluates the SDHAF2 gene for mutations linked to hereditary paraganglioma-pheochromocytoma syndrome type 5. | Peripheral Whole Blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| SDHD Gene Cowden Syndrome Type 3 Genetic Test TEST-2107 LOINC 65607-2 | This test evaluates the SDHD gene for pathogenic mutations associated with Cowden syndrome type 3, a hereditary cancer predisposition syndrome. | Whole Blood (Peripheral) | 21–28 Days (3 to 4 Weeks) | 2,800.00 AED | Details |
| SDHD Gene Pheochromocytoma Type 1 Genetic Test TEST-1936 LOINC 21763-6 | This genetic test evaluates the SDHD gene for pathogenic variants associated with hereditary pheochromocytoma-paraganglioma syndrome. | Peripheral Whole Blood (EDTA) or Extracted DNA | 3–4 Weeks | 2,800.00 AED | Details |
| SRGAP1 Gene Mutation Analysis for Hereditary Nonmedullary Thyroid Cancer (Type 2) Test TEST-1891 LOINC 21636-6 | This genetic test identifies mutations in the SRGAP1 gene linked to hereditary nonmedullary thyroid cancer type 2. | Peripheral blood, extracted DNA, or dried blood spot (FTA card) | 3–4 Weeks | 2,800.00 AED | Details |
| STAG1 Gene Prostate Cancer Genetic Test TEST-1908 LOINC 21620-6 | This test evaluates the STAG1 gene for variants associated with an increased risk of hereditary prostate cancer. | Peripheral Whole Blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| STK11 Gene (Peutz-Jeghers Syndrome) Genetic Test TEST-1941 LOINC 85196-1 | This genetic test evaluates the STK11 gene for mutations associated with Peutz-Jeghers syndrome, a hereditary condition increasing cancer risk. | Peripheral Whole Blood | 3 – 4 Weeks | 2,800.00 AED | Details |
| SUFU Gene Basal Cell Nevus Syndrome Genetic Test TEST-2141 LOINC 90278-2 | This test evaluates the SUFU gene for pathogenic variants associated with Nevoid Basal Cell Carcinoma Syndrome (Gorlin syndrome). | Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) | 3 – 4 weeks | 2,800.00 AED | Details |
| SUFU Gene Sequencing for Familial Desmoplastic Medulloblastoma (NGS) Test TEST-2029 LOINC 55233-1 | This test analyzes the SUFU gene for germline pathogenic variants associated with familial desmoplastic medulloblastoma. | Whole Blood (EDTA tube), Extracted Genomic DNA (≥3 µg), or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| TGFBR2 Gene Colorectal Cancer, Hereditary Nonpolyposis Type 6 Genetic Test TEST-2094 LOINC 48000-4 | This test evaluates the entire TGFBR2 gene for germline mutations associated with an increased risk of hereditary colorectal cancer. | Whole blood (Peripheral) | 3–4 weeks | 2,800.00 AED | Details |
| TP53 Mutation Analysis (NGS) Test TEST-1310 LOINC 21647-9 | This test evaluates for mutations within the TP53 gene, a critical tumour suppressor gene. | Peripheral blood (EDTA whole blood) or bone marrow aspirate | 15–18 business days | 6,000.00 AED | Details |
| WT-1 Mutation Detection Test TEST-3452 LOINC 92918-3 | This test detects pathogenic variants in the WT1 gene associated with Wilms tumor and related syndromes. | Blood or bone marrow | 18 working days | 1,800.00 AED | Details |
| XRCC3 Gene (Breast Cancer Susceptibility) Genetic Test TEST-2117 LOINC 55233-1 | This test evaluates the XRCC3 gene for pathogenic variants associated with an increased risk of hereditary breast cancer. | Whole blood EDTA | 3 to 4 weeks from specimen receipt | 2,800.00 AED | Details |
| ZNF783 Gene Prostate Cancer Genetic Test TEST-1915 LOINC 101262-9 | This test evaluates for mutations in the ZNF783 gene, which are associated with an increased risk of developing prostate cancer. | Peripheral Whole Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
Clinical overview
About Cancer Genetics
Empowering yourself with a deep understanding of your family’s oncological history is the most effective way to protect your future wellness. As a core pillar of our advanced Molecular Genetics department, comprehensive Cancer Genetics screening provides an in-depth evaluation of the complex hereditary pathways linked to various cancer syndromes. By leveraging cutting-edge genomic technology, this expansive screening delivers the critical clarity required to assess inherited risks, safely guiding customized oncology oversight, specialized prophylactic strategies, and informed family planning. Consistently ranked among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable turnaround times. Prioritize your preventative health—book your cancer genetics testing in UAE, arrange a comfortable home sample collection, or consult our specialized genetic counselors.
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted — please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Cancer Genetics testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Cancer Genetics test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book — please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Cancer Genetics page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves — it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative — confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Cancer Genetics test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option — including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas